HIG Capital to sell Celerion to THL Partners

Celerion’s services include data management, biostatistics, and clinical monitoring that supports pharmaceutical and biotechnology customers.

22 April 2026•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals North America US Healthcare Briefs